Top Markets
#1 Akedo Akedo +71.59%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +48.61%
#4 Cross Cross +34.10%
#5 Black Phoenix Black Phoenix +33.95%
#6 Cap Cap +29.61%
#7 Velvet Velvet +26.32%
#8 Ravencoin Ravencoin +17.91%
#9 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +16.35%
#10 DoubleZero DoubleZero +12.07%
Coin of the day
Akedo Akedo
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Lipidor AB (publ) Lipidor AB (publ)

Lipidor AB (publ)

LIPI
Rang in aandelen #39101
Lipidor AB (publ), a Swedish pharmaceutical company founded in Danderyd in... Lipidor AB (publ), a Swedish pharmaceutical company founded in Danderyd in 2009, specializes in developing medicinal products. Its core business centers on creating treatments for various skin conditions, including psoriasis, bacterial skin infections, and atopic dermatitis. The company's product pipeline includes AKP-01, which is currently in Phase III clinical trials for psoriasis, while other formulations like AKP-02 (also for psoriasis) and AKP-03 and AKP-07 (for eczema) are in earlier, preclinical development stages. Beyond its own drug candidates, Lipidor manufactures and supplies active pharmaceutical ingredients (APIs). These APIs are incorporated into products addressing a broad spectrum of therapeutic applications, such as managing psoriasis, microbial infections, inflammation, fungal issues, local pain relief, acne, wound healing, eczema, and migraines. Lipidor also caters to the animal health market, offering a line of spray-on skin care products for dogs, cats, and horses. Additionally, it develops consumer health items designed for purposes like antibacterial action, antiseptic care, moisturizing, disinfection, and treating acne and warts. In a key strategic alliance, Lipidor has partnered with Cannassure Therapeutics Ltd. This collaboration aims to advance topical medicinal cannabis products specifically formulated to alleviate skin inflammations and psoriatic lesions.
Aandeelprijs
$0.02243487
Laatst gesynchroniseerd: 2025-06-04
Marktkapitalisatie
$650.09K
Verandering (1 dag)
0.39%
Verandering (1 jaar)
0.00%
Land
SE
Handel Lipidor AB (publ) (LIPI)

Categorie

Healthcare
Winst voor Lipidor AB (publ) (LIPI)
Winst in Dec 2024 TTM: $-1.25M
Volgens de meest recente financiële verslagen van Lipidor AB (publ) bedraagt de huidige winst van het bedrijf $-1.25M. In 2023 behaalde het bedrijf een winst van $-1.14M, een stijging ten opzichte van de winst van 2022, die $-3.97M bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van Lipidor AB (publ) van 2016 tot 2026
Winst aan het einde van elk jaar
Jaar Winst Wijzigen
2026 (TTM) $-1.25M 0.00%
2024 $-1.25M 9.96%
2023 $-1.14M -71.31%
2022 $-3.97M 68.68%
2021 $-2.35M 19.98%
2020 $-1.96M 32.57%
2019 $-1.48M 73.02%
2018 $-854.84K 129.77%
2017 $-372.04K -30.69%
2016 $-536.78K 0.00%
Winst van vergelijkbare bedrijven of concurrenten
Bedrijf Winst Winstverschil Land
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
$33.59B -2,683,842.70%
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
$25.20B -2,012,923.00%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
$8.70B -695,033.61%
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
$21.39B -1,708,738.18%
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
$5.95B -475,265.55%
US